200,000+ products from a single source!

sales@angenechem.com

Home > Thiazole > 30216-51-4

30216-51-4

30216-51-4 | 2-Hydrazinylthiazole

CAS No: 30216-51-4 Catalog No: AG007J9W MDL No:MFCD05863227

Product Description

Catalog Number:
AG007J9W
Chemical Name:
2-Hydrazinylthiazole
CAS Number:
30216-51-4
Molecular Formula:
C3H5N3S
Molecular Weight:
115.1569
MDL Number:
MFCD05863227
IUPAC Name:
1,3-thiazol-2-ylhydrazine
InChI:
InChI=1S/C3H5N3S/c4-6-3-5-1-2-7-3/h1-2H,4H2,(H,5,6)
InChI Key:
BTWNEJOURYOHME-UHFFFAOYSA-N
SMILES:
NNc1nccs1

Properties

Complexity:
58.1  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
115.02g/mol
Formal Charge:
0
Heavy Atom Count:
7  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
115.154g/mol
Monoisotopic Mass:
115.02g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
79.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.5  

Literature

Title Journal
Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives. European journal of medicinal chemistry 20080501
Synthesis and in vitro activity of 2-thiazolylhydrazone derivatives compared with the activity of clotrimazole against clinical isolates of Candida spp. Bioorganic & medicinal chemistry letters 20070815
Syntheses of aromatic substituted hydrazino-thiazole derivatives to clarify structural characterization and antioxidant activity between 3-arylsydnonyl and aryl substituted hydrazino-thiazoles. Chemical & pharmaceutical bulletin 20070801
Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives. Journal of medicinal chemistry 20070222
Synthesis, antibacterial and antifungal activity of some new thiazolylhydrazone derivatives containing 3-substituted cyclobutane ring. European journal of medicinal chemistry 20060201

Related Products

© 2019 Angene International Limited. All rights Reserved.